Prosecution Insights
Last updated: October 02, 2026

Lungpacer Medical Inc.

Technology area: Medical Devices & Mechanical Engineering

5 pending office actions • 2 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Lungpacer Medical Inc. has 5 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 4 distinct examiners, with GEDEON, BRIAN T serving as the busiest examiner. This individual is responsible for 2 pending office actions, while the remaining matters are split among the other distinct examiners.

The portfolio's current activity is situated within 2 distinct art units, indicating a focused technical scope for the company's medical device innovations. With 5 pending office actions and 4 distinct examiners, the company faces a relatively concentrated group of USPTO personnel. The busiest examiner, GEDEON, BRIAN T, handles 2 of these actions, making his decisions particularly influential for the portfolio.

Practitioners should account for the 2 distinct art units when developing prosecution strategies for the 5 pending office actions. Because there are 4 distinct examiners involved, the company must manage several different examination approaches within a narrow technical field defined by the 2 distinct art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
2
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (20%)
Double-patenting + other1 (20%)
Multi-statute (no §101)3 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
60% of docket
2
Business / Other
40% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GEDEON, BRIAN T 2 86.9% +7.2%
MARSH, OWEN LEWIS 1 66.7% +50.0%
GHAND, JENNIFER LEIGH-STEWAR 1 60.5% +27.8%
EDWARDS, PHILIP CHARLES 1 85.1% +15.2%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19237863 TRANSVASCULAR DIAPHRAGM PACING SYSTEMS AND METHODS OF USE GEDEON, BRIAN T —

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18605386 SYSTEMS AND METHODS FOR TRANS-ESOPHAGEAL SYMPATHETIC GANGLION RECRUITMENT GHAND, JENNIFER LEIGH-STEWAR 3d overdue
18736214 Systems and methods for intravascular catheter positioning and/or nerve stimulation GEDEON, BRIAN T —
17663064 SYSTEMS AND METHODS FOR SENSING AND STIMULATION EDWARDS, PHILIP CHARLES —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18605386 SYSTEMS AND METHODS FOR TRANS-ESOPHAGEAL SYMPATHETIC GANGLION RECRUITMENT GHAND, JENNIFER LEIGH-STEWAR 3d overdue
19029261 TRANSVASCULAR NERVE STIMULATION APPARATUS AND METHODS MARSH, OWEN LEWIS —
17663064 SYSTEMS AND METHODS FOR SENSING AND STIMULATION EDWARDS, PHILIP CHARLES —

Top Art Units

Art UnitApps
3796 2
3792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19237863 TRANSVASCULAR DIAPHRAGM PACING SYSTEMS AND METHODS OF USE GEDEON, BRIAN T 3796 §103DP Non-Final OA — Pending Jun 13, 2025
19029261 TRANSVASCULAR NERVE STIMULATION APPARATUS AND METHODS MARSH, OWEN LEWIS — §103 Non-Final OA — Pending Jan 17, 2025
18736214 Systems and methods for intravascular catheter positioning and/or nerve stimulation GEDEON, BRIAN T — §102§103 Non-Final OA — Pending Jun 06, 2024
18605386 SYSTEMS AND METHODS FOR TRANS-ESOPHAGEAL SYMPATHETIC GANGLION RECRUITMENT GHAND, JENNIFER LEIGH-STEWAR 3796 §102§103§112 Final Rejection 3d overdue Pending Mar 14, 2024
17663064 SYSTEMS AND METHODS FOR SENSING AND STIMULATION EDWARDS, PHILIP CHARLES 3792 §103§112 Final Rejection — Pending May 12, 2022

Managing Lungpacer Medical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month